Literature DB >> 28953021

Understanding medulloblastoma.

Alyssa Quinlan1, Denise Rizzolo.   

Abstract

Brain tumors are the most common solid tumor malignancies in childhood, and among them, medulloblastoma occurs with the greatest frequency. Because medulloblastomas occur in the posterior fossa, the presenting symptoms often are vague complaints and diagnosis may be delayed. Between 70% and 80% of patients who are diagnosed before metastatic dissemination survive, compared with 30% to 40% of those in higher risk groups. This article reviews the diagnosis, treatment, and prognosis for medulloblastoma.

Entities:  

Mesh:

Year:  2017        PMID: 28953021     DOI: 10.1097/01.JAA.0000524717.71084.50

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  11 in total

1.  Prognostic Value of miR-137 in Children with Medulloblastoma and its Regulatory Effect on Tumor Progression.

Authors:  Wenyuan Ji; Xuan Zhe; Lusheng Li; Yang Cheng; Xueling Zhao; Ping Liang; Chunxi Long; Jianjun Zhou
Journal:  Neuromolecular Med       Date:  2021-08-18       Impact factor: 3.843

2.  Prognostic role of NLGN2 and PTGDS in medulloblastoma based on gene expression omnibus.

Authors:  Zhangping Ren; Ming Gao; Wei Jiang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  KIF26B Is Overexpressed in Medulloblastoma and Promotes Malignant Progression by Activating the PI3K/AKT Pathway.

Authors:  Yajun Liu; Xi Zhang; Ruihan Pan; Xiaolong Liang; Qichang Liu; Chao Yang; Xu Li
Journal:  Anal Cell Pathol (Amst)       Date:  2022-07-12       Impact factor: 4.133

Review 4.  Protective Mechanisms Against DNA Replication Stress in the Nervous System.

Authors:  Clara Forrer Charlier; Rodrigo A P Martins
Journal:  Genes (Basel)       Date:  2020-06-30       Impact factor: 4.096

Review 5.  Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.

Authors:  Han Zou; Brad Poore; Alberto Broniscer; Ian F Pollack; Baoli Hu
Journal:  Cancers (Basel)       Date:  2020-03-10       Impact factor: 6.639

Review 6.  HGF/MET Signaling in Malignant Brain Tumors.

Authors:  Elizabeth Qian Xu Mulcahy; Rossymar Rivera Colόn; Roger Abounader
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

7.  External Validation of a Nomogram and Risk Grouping System for Predicting Individual Prognosis of Patients With Medulloblastoma.

Authors:  Chengcheng Guo; Dunchen Yao; Xiaoping Lin; He Huang; Ji Zhang; Fuhua Lin; Yonggao Mou; Qunying Yang
Journal:  Front Pharmacol       Date:  2020-11-11       Impact factor: 5.810

8.  microRNA-155-3p delivered by M2 macrophages-derived exosomes enhances the progression of medulloblastoma through regulation of WDR82.

Authors:  Li Song; Bin Luan; Qingrong Xu; Ruihe Shi; Xiufang Wang
Journal:  J Transl Med       Date:  2022-01-04       Impact factor: 5.531

9.  Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway.

Authors:  Weiyi Gong; Wenxuan Zhao; Gang Liu; Lei Shi; Xia Zhao
Journal:  Aging (Albany NY)       Date:  2022-07-06       Impact factor: 5.955

Review 10.  Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups.

Authors:  Emilia Bevacqua; Jasmin Farshchi; Maria Victoria Niklison-Chirou; Paola Tucci
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.